These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9600719)

  • 1. Distribution of bismuth in the rat after oral dosing with ranitidine bismuth citrate and bismuth subcitrate.
    Canena J; Reis J; Pinto AS; Santos AM; Leitão J; Pinheiro T; Quina MG
    J Pharm Pharmacol; 1998 Mar; 50(3):279-83. PubMed ID: 9600719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).
    Lacey LF; Frazer NM; Keene ON; Smith JT
    Eur J Clin Pharmacol; 1994; 47(2):177-80. PubMed ID: 7859806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of bismuth and ranitidine following multiple doses of ranitidine bismuth citrate.
    Koch KM; Kerr BM; Gooding AE; Davis IM
    Br J Clin Pharmacol; 1996 Aug; 42(2):207-11. PubMed ID: 8864319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
    Vakil N; Cutler A
    Am J Gastroenterol; 1999 May; 94(5):1197-9. PubMed ID: 10235192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of bismuth and ranitidine following single doses of ranitidine bismuth citrate.
    Koch KM; Davis IM; Gooding AE; Yin Y
    Br J Clin Pharmacol; 1996 Aug; 42(2):201-5. PubMed ID: 8864318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal and systemic uptake of bismuth in mice after oral exposure.
    Larsen A; Martiny N; Stoltenberg M; Danscher G; Rungby J
    Pharmacol Toxicol; 2003 Aug; 93(2):82-90. PubMed ID: 12899670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine bismuth citrate in the treatment of Helicobacter pylori infection and duodenal ulcer.
    Vondracek TG
    Ann Pharmacother; 1998 Jun; 32(6):672-9. PubMed ID: 9640487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
    Tam YH; Yeung CK; Lee KH
    Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate.
    Stables R; Campbell CJ; Clayton NM; Clitherow JW; Grinham CJ; McColm AA; McLaren A; Trevethick MA
    Aliment Pharmacol Ther; 1993 Jun; 7(3):237-46. PubMed ID: 8364129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-day therapy with ranitidine bismuth citrate plus low-dose clarithromycin and tinidazole to cure Helicobacter pylori infection.
    Cammarota G; Cannizzaro O; Cianci R; Gasbarrini A; Pirozzi G; Gasbarrini G
    Hepatogastroenterology; 2000; 47(34):1176-9. PubMed ID: 11020908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranitidine bismuth citrate: a novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrate-ranitidine admixture.
    McColm AA; McLaren A; Klinkert G; Francis MR; Connolly PC; Grinham CJ; Campbell CJ; Selway S; Williamson R
    Aliment Pharmacol Ther; 1996 Jun; 10(3):241-50. PubMed ID: 8791946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients.
    Avşar E; Tiftikçi A; Poturoğlu S; Erzin Y; Kocakaya O; Dinçer D; Yıldırım B; Güliter S; Türkay C; Yılmaz U; Onuk MD; Bölükbaş C; Ellidokuz E; Bektaş A; Taşan G; Aytuğ N; Ateş Y; Kaymakoğlu S
    Turk J Gastroenterol; 2013; 24(4):316-21. PubMed ID: 24254262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of Helicobacter pylori eradication therapy on bismuth absorption of colloidal bismuth subcitrate].
    Zhang L; Zhang ST; Yu ZL; Shao Y
    Zhonghua Nei Ke Za Zhi; 2005 Apr; 44(4):272-5. PubMed ID: 15924641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of trough plasma bismuth concentrations.
    Bennett JE; Wakefield JC; Lacey LF
    J Pharmacokinet Biopharm; 1997 Feb; 25(1):79-106. PubMed ID: 9353695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
    Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of administration of ranitidine bismuth citrate with food on the suppression and eradication of Helicobacter pylori in infected volunteers.
    Webb DD; Ciociola AA; Perschy TB; Goodwin BB
    Am J Gastroenterol; 1995 Aug; 90(8):1273-7. PubMed ID: 7639229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication.
    Akyildiz M; Akay S; Musoglu A; Tuncyurek M; Aydin A
    Eur J Intern Med; 2009 Jan; 20(1):53-7. PubMed ID: 19237093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer.
    Bardhan KD; Dallaire C; Eisold H; Duggan AE
    Gut; 1997 Aug; 41(2):181-6. PubMed ID: 9301496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.